PUNE, India and SANTA CLARA, California, April 3, 2020 /PRNewswire/ — COVID-19 is now a global humanitarian challenge that is impacting every facet of our lives – from our health, to the economy, to the ways we engage as a society at large. And it is only through the collaboration and ingenuity across both public and private sectors that this challenge will be addressed and its impact mitigated.
In response to the COVID-19 pandemic, Chairman of Board, Anand Deshpande and CEO, Chris O’Connor jointly announced that Persistent Systems is donating Rs. 25 Crores ($3.3M) to support various aspects of the global response.
Quote from Dr. Anand Deshpande, Chairman and Managing Director, Persistent Systems
“The effect of COVID-19 on our global and local communities is profound and it will have a lasting impact. In this unprecedented time of need, we at Persistent must step-up, alongside many leaders from across industries and governments, to address the challenge, search for treatments/vaccines as well as support victims, their families and local communities. We are truly in this together.”
About Persistent Systems:
Persistent Systems (BSE: PERSISTENT) (NSE: PERSISTENT) is a global solutions company delivering digital business acceleration, enterprise modernization and digital product engineering for businesses across all industries and geographies.
Forward-looking and Cautionary Statements: For risks and uncertainties relating to forward-looking statements, please visit www.persistent.com/FLCS
Media Contacts:
Saviera Barretto
Archetype (India)
+91 84249 17719
saviera.barretto@archetype.co
Ken Montgomery
Persistent Systems (Global)
+1 213 500 8355
ken_montgomery@persistent.com
SOURCE Persistent Systems
First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing…
Vancouver, British Columbia--(Newsfile Corp. - March 20, 2024) - Delivra Health Brands Inc. (TSXV: DHB)…
New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens…
Pioneering the Path of Sound Therapy with Biofield TuningBURLINGTON, VERMONT / ACCESSWIRE / March 20,…
ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or…
LOS ANGELES, CA / ACCESSWIRE / March 20, 2024 / The Skirball Cultural Center was…